GORDON CARL L
CIK 1282930
Transactions on file
10
Open-market buys
5
Win rate (buys)
100%
5 scored
Avg % since filing (buys)
+358.8%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Buy | 1,000,000 | $15.00M | +29.7% | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | C | 348,825 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +415.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +464.8% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +467.7% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +415.9% | open → |
| 2025-04-11 | 2025-04-09 | CMPX Compass Therapeutics, Inc. | Director10% | Sale | 3,571,428 | $5.68M | — | open → |
| 2025-06-06 | 2025-06-04 | KROS Keros Therapeutics, Inc. | Director | Grant | 5,250 | $0.00 | — | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 74,465 | $1.32M | -43.3% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 140,057 | $2.49M | -43.3% | open → |
